Cargando…

Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus

Retroviral infection involves the reverse transcription of the viral RNA genome into DNA, which is subsequently integrated into the host cell genome. HIV-1 and other lentiviruses are able to mediate the infection of non-dividing cells through the ability of the capsid (CA) protein (1) to engage the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dharan, Adarsh, Bachmann, Niklas, Talley, Sarah, Zwikelmaier, Virginia, Campbell, Edward M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286700/
https://www.ncbi.nlm.nih.gov/pubmed/32483230
http://dx.doi.org/10.1038/s41564-020-0735-8
_version_ 1784748075909120000
author Dharan, Adarsh
Bachmann, Niklas
Talley, Sarah
Zwikelmaier, Virginia
Campbell, Edward M.
author_facet Dharan, Adarsh
Bachmann, Niklas
Talley, Sarah
Zwikelmaier, Virginia
Campbell, Edward M.
author_sort Dharan, Adarsh
collection PubMed
description Retroviral infection involves the reverse transcription of the viral RNA genome into DNA, which is subsequently integrated into the host cell genome. HIV-1 and other lentiviruses are able to mediate the infection of non-dividing cells through the ability of the capsid (CA) protein (1) to engage the cellular nuclear import pathways of the target cell and mediate their nuclear translocation through components of the nuclear pore complex (NPC) (2–4). Although recent studies have observed the presence of capsid in the nucleus during infection(5–8), reverse transcription and disassembly of the viral core have conventionally been considered to be cytoplasmic events. Here, we use an inducible nuclear pore blockade to monitor the kinetics of HIV-1 nuclear import and define the biochemical staging of these steps of infection. Surprisingly, we observe that nuclear import occurs with relatively rapid kinetics (<5 hours) and precedes the completion of reverse transcription in target cells, demonstrating that reverse transcription completes in the nucleus. We also observe that HIV-1 remains susceptible to a capsid destabilizing compound PF74 following nuclear import, revealing that uncoating completes in the nucleus. We also observe that certain CA mutants are insensitive to a Nup62 mediated nuclear pore blockade in cells which potently block infection by wild type CA, demonstrating that HIV-1 can utilize distinct nuclear import pathways during infection. These studies collectively define the spatiotemporal staging of critical steps of HIV-1 infection and provide an experimental system to separate and thereby define the cytoplasmic and nuclear stages of infection by other viruses.
format Online
Article
Text
id pubmed-9286700
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-92867002022-07-15 Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus Dharan, Adarsh Bachmann, Niklas Talley, Sarah Zwikelmaier, Virginia Campbell, Edward M. Nat Microbiol Article Retroviral infection involves the reverse transcription of the viral RNA genome into DNA, which is subsequently integrated into the host cell genome. HIV-1 and other lentiviruses are able to mediate the infection of non-dividing cells through the ability of the capsid (CA) protein (1) to engage the cellular nuclear import pathways of the target cell and mediate their nuclear translocation through components of the nuclear pore complex (NPC) (2–4). Although recent studies have observed the presence of capsid in the nucleus during infection(5–8), reverse transcription and disassembly of the viral core have conventionally been considered to be cytoplasmic events. Here, we use an inducible nuclear pore blockade to monitor the kinetics of HIV-1 nuclear import and define the biochemical staging of these steps of infection. Surprisingly, we observe that nuclear import occurs with relatively rapid kinetics (<5 hours) and precedes the completion of reverse transcription in target cells, demonstrating that reverse transcription completes in the nucleus. We also observe that HIV-1 remains susceptible to a capsid destabilizing compound PF74 following nuclear import, revealing that uncoating completes in the nucleus. We also observe that certain CA mutants are insensitive to a Nup62 mediated nuclear pore blockade in cells which potently block infection by wild type CA, demonstrating that HIV-1 can utilize distinct nuclear import pathways during infection. These studies collectively define the spatiotemporal staging of critical steps of HIV-1 infection and provide an experimental system to separate and thereby define the cytoplasmic and nuclear stages of infection by other viruses. 2020-09 2020-06-01 /pmc/articles/PMC9286700/ /pubmed/32483230 http://dx.doi.org/10.1038/s41564-020-0735-8 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Dharan, Adarsh
Bachmann, Niklas
Talley, Sarah
Zwikelmaier, Virginia
Campbell, Edward M.
Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus
title Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus
title_full Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus
title_fullStr Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus
title_full_unstemmed Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus
title_short Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus
title_sort nuclear pore blockade reveals hiv-1 completes reverse transcription and uncoating in the nucleus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286700/
https://www.ncbi.nlm.nih.gov/pubmed/32483230
http://dx.doi.org/10.1038/s41564-020-0735-8
work_keys_str_mv AT dharanadarsh nuclearporeblockaderevealshiv1completesreversetranscriptionanduncoatinginthenucleus
AT bachmannniklas nuclearporeblockaderevealshiv1completesreversetranscriptionanduncoatinginthenucleus
AT talleysarah nuclearporeblockaderevealshiv1completesreversetranscriptionanduncoatinginthenucleus
AT zwikelmaiervirginia nuclearporeblockaderevealshiv1completesreversetranscriptionanduncoatinginthenucleus
AT campbelledwardm nuclearporeblockaderevealshiv1completesreversetranscriptionanduncoatinginthenucleus